Mallinckrodt Expected to Pay $15.4M to DOJ Over Acthar Scandal

Mallinckrodt Pharmaceuticals announced today that the company expects to pay $15.4 million in a settlement with the U.S. Justice Department after allegations that Questcor Pharmaceuticals, which Mallinckrodt acquired in 2014, had bribed doctors and their staff to prescribe an incredibly expensive dr